Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 2, Pages 383
Publisher
MDPI AG
Online
2019-01-18
DOI
10.3390/ijms20020383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells
- (2017) Gustav Steinemann et al. MOLECULAR CANCER THERAPEUTICS
- Structural Basis of cis - and trans -Combretastatin Binding to Tubulin
- (2017) Roberto Gaspari et al. Chem
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
- (2016) Yang Hai et al. Nature Chemical Biology
- Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
- (2016) Peter J. Watson et al. Nature Communications
- Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment
- (2015) Arvind S. Negi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents
- (2015) Katharina Mahal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity
- (2015) Stefan Huber et al. CYTOMETRY PART A
- Panobinostat: First Global Approval
- (2015) Karly P. Garnock-Jones DRUGS
- Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
- (2015) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 4-(1-Ethyl-4-anisyl-imidazol-5-yl)-N-hydroxycinnamide – A new pleiotropic HDAC inhibitor targeting cancer cell signalling and cytoskeletal organisation
- (2015) Katharina Mahal et al. EXPERIMENTAL CELL RESEARCH
- Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation
- (2015) Katharina Mahal et al. INVESTIGATIONAL NEW DRUGS
- Torsion Library Reloaded: A New Version of Expert-Derived SMARTS Rules for Assessing Conformations of Small Molecules
- (2015) Wolfgang Guba et al. Journal of Chemical Information and Modeling
- Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer
- (2015) Zhuang Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels
- (2014) Katharina Mahal et al. ChemMedChem
- Belinostat: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Design, synthesis, and preliminary bioactivity studies of substituted purine hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors
- (2014) Junhua Wang et al. MedChemComm
- The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
- (2013) Xuan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents
- (2013) Katharina Mahal et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Torsion Angle Preferences in Druglike Chemical Space: A Comprehensive Guide
- (2013) Christin Schärfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combretazet-3 a novel synthetic cis-stable combretastatin A-4- azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer
- (2013) LISA M. GREENE et al. ONCOLOGY REPORTS
- p53 acetylation enhances Taxol-induced apoptosis in human cancer cells
- (2012) Jae Hyeong Kim et al. APOPTOSIS
- Actin stress fibers - assembly, dynamics and biological roles
- (2012) S. Tojkander et al. JOURNAL OF CELL SCIENCE
- A consistent description of HYdrogen bond and DEhydration energies in protein–ligand complexes: methods behind the HYDE scoring function
- (2012) Nadine Schneider et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
- (2012) Dejuan Kong et al. PLoS One
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
- (2011) Valentina Zuco et al. PLoS One
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles That Are Cytotoxic against Combretastatin A Resistant Tumor Cells and Vascular Disrupting in a Cisplatin Resistant Germ Cell Tumor Model
- (2010) Rainer Schobert et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now